Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 284 results for "kexin"

Recently Approved Cholesterol Medication May Increase US Health Costs
MedIndia

PCSK9 inhibitors and diabetes risk: a question worth asking?

This editorial refers to No effect of the proprotein convertase subtilisin/kexin type 9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY Phase 3 studies, by H.M. Colhoun et al. , doi:10.1093/eurheartj/ehw292. ... European Heart Journal, 3 hours ago
PCSK9 Inhibitors Now Too Pricey in Cost-effectiveness Analysis Dermatology Online Journal, 1 week ago
[x]  

5 images for kexin

Spy News Agency, 5 days ago
Spy News Agency, 5 days ago
MDLinx, 4 months ago
Medical Xpress, 5 months ago
Pharmaceutical Business Review, 5 months ago

Sympatric speciation of Acomys in Evolution Canyon [Evolution]

Kexin Li a , b , 1 , 2 , Huihua Wang a , 1 , Zhenyuan Cai c , 1 , Liuyang Wang d , Qinqin Xu e , Matěj Lövy b , f , Zhenlong Wang g , 2 , and Eviatar Nevo b , 2 a Institute of Apicultural Research, Chinese Academy of Agricultural Sciences ...
 PNAS1 month ago Sympatric speciation of Spalax in chalk and basalt [Evolution]  PNAS1 month ago
NBCNews.com

China's Olympian Factories Churn Out Fewer Champions

Cheng Fei, Deng Linlin, He Kexin, Jiang Yuyuan, Li Shanshan and Yang Yilin of the Chinese women's gymnastics team look on after winning the gold medal at the Beijing 2008 Olympic Games. Al Bello / Not all retired athletes in China are as ...
 NBCNews.com4 days ago Rio 2016: China's Olympian Factories Churn Out Fewer Champions  Spy News Agency5 days ago

Briefs | UM student wins Tomás Pereira Prize

Zhang Kexin Zhang Kexin, an undergraduate student from the University of Macau's Department of Portuguese, recently won an award in the first-year category of the Tomás Pereira Prize. The prize is awarded annually to the best Chinese university ...
 Macau Daily Times1 month ago
Nasdaq

Regeneron Says Japan Approves Praluent To Treat Hypercholesterolemia

Praluent is a human monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9). In Japan, Praluent is indicated for the treatment of patients with hypercholesterolemia and familial hypercholesterolemia (FH) who are at high ...
 Nasdaq1 month ago Regeneron and Sanofi Announce Approval of Praluent(R) (alirocumab) for the Treatment of Hypercholesterolemia in Japan  Healthcare Sales & Marketing Network1 month ago REGENERON PHARMACEUTICALS : and Sanofi Announce Approval of Praluent® alirocumab for the Treatment of Hypercholesterolemia in Japan  4 Traders1 month ago Japan Authorizes Sanofi/Regeneron's Praluent  PharmaAsia1 month ago
[x]  

China's Golden Concord Said to Compete for SunEdison Yieldco

Golden Concord Holdings Ltd., the Chinese clean-energy group, is seeking to acquire assets from bankrupt U.S. renewable-energy giant SunEdison Inc., people familiar with the company's plans said. Golden Concord is planning to bid for SunEdison's ...
 Bloomberg4 hours ago
MyNewsDesk

Global Paraquat TC analysis for 2016 shared in new research report

(Before It's News) ACCESS REPORT @ https://www.wiseguyreports.com/reports/global-paraquat-tc-sales-market-report-2016 Notes: Sales, means the sales volume of Paraquat TC Revenue, means the sales value of Paraquat TC This report ...
 Before It's News9 hours ago Global PARAQUAT TC Market Forecast to 2021 Covering Investment Feasibility, Company Profiles, Competitive Landscape, and Industry Chain Structure  Empowered News1 month ago Universal Testing Machine Global and China Sales, Ex-factory Price, Revenue, Gross Margin Analysis 2016  Press Release Ping1 month ago Pressure Vessel Market Competitive Landscape Analysis and Major Regions Development Status  MyNewsDesk1 month ago

Mandrola Previews European Society of Cardiology 2016 Congress

When asked which medical meeting is my favorite, I don't hesitate. It's the European Society of Cardiology (ESC) Congress . Just the fact that they call it a "congress" is cool. No disrespect to American meetings, but I live here; I pretty much ...
 Dermatology Online Journal2 days ago AMGEN : New Data Add To Understanding Of Repatha(R) (Evolocumab) In Multiple Patient Populations  4 Traders3 days ago New data adds to understanding of Repatha® (evolocumab) in multiple patient populations  CPhI.cn19 hours ago AMGEN : New data adds to understanding of Repatha® (evolocumab) in multiple patient populations  4 Traders2 days ago
[x]  
Share Market Updates

CDSCO Denies Amgen, Inc. (NASDAQ:AMGN) Clinical Trial Waiver For Repatha

The Central Drugs Standard Control Organization (CDSCO) has hampered the plans of Amgen, Inc. (NASDAQ:AMGN) to quickly commercialize Repatha (evolocumab), a proprotein convertase subtilisin/kexin type 9 (PCSK9) drug, in India. Clinical Trial Waiver ...
 4 Traders1 day ago HC Stocks to Path: Amgen, Inc. (NASDAQ:AMGN), Opko Health Inc. (NASDAQ:OPK)  Share Market Updates1 month ago HC Stocks Indications: Sanofi SA (ADR) (NYSE:SNY), Express Scripts Holding Company (NASDAQ:ESRX)  Share Market Updates1 month ago HC Stocks Highlights: Pfizer Inc. (NYSE:PFE), Valeant Pharmaceuticals Intl Inc (NYSE:VRX)  Share Market Updates1 month ago

NOVARTIS AG (NYSE : NVS) Licenses LGT209 To Cyon Therapeutics, Inc., Teams Up With KRCS

Novartis AG (NYSE:NVS) has recently entered into a licensing agreement with Cyon Therapeutics, Inc. for the licensing of LGT209, a proprotein convertase subtilisin/kexin type 9 (PCSK9) antibody. Licensing Agreement Under the agreement, Cyon ...
 4 Traders1 day ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less